Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
about
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationCost of AF Ablation: Where Do We Stand?Warfarin: almost 60 years old and still causing problemsShensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical TrialsChallenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A ReviewAccuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysisSafety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataCardiomyocyte Remodeling in Atrial Fibrillation and Hibernating Myocardium: Shared Pathophysiologic Traits Identify Novel Treatment Strategies?The Cost Effectiveness of LAA ExclusionUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsAtrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillationPro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atriaUsing Phase-Based Costing of Real-World Data to Inform Decision-Analytic Models for Atrial Fibrillation.The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort DataDietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model.Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?Atrial fibrillation: the current epidemicFibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).Current perceptions of the epidemiology of atrial fibrillation.Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.Obesity and atrial fibrillation.Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study.Improving ablation strategies for the treatment of atrial fibrillation.Surgical treatment of atrial fibrillation: a reviewUpdate on anti-coagulation in atrial fibrillation.Atrial fibrillation: the cost of illness in SwedenThe burden of atrial fibrillation in the Netherlands.LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.Advances in imaging for atrial fibrillation ablation.Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.3D virtual human atria: A computational platform for studying clinical atrial fibrillationThe current cost of angina pectoris to the National Health Service in the UK.Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.Living on a knife edge-the daily struggle of coping with symptomatic cardiac arrhythmias.Antithrombotic treatment in atrial fibrillation.Identification, diagnosis and assessment of atrial fibrillation.Stroke Prevention in Atrial Fibrillation: Where are We Now?Cost considerations in the management of atrial fibrillation - impact of dronedarone.
P2860
Q24202280-B4032CF1-26AC-4488-B8FD-29517C4CD997Q24605888-56757507-2495-4560-B71D-1F8412921D86Q24678632-2D913A64-BA47-44AF-A53C-9812C58F667FQ26753062-7928176F-0695-4555-AF93-CD9F9D002F8AQ26765949-69DD870B-241E-4DC5-B247-99F1362E090DQ26783524-D7645BD4-6D6E-4F51-8A51-6A465B4F2C93Q26796271-CE4DA7A0-6EF2-4BB9-8007-EC67DFD4358AQ26801890-594EB3B8-99C4-485D-930C-77683F2E1636Q28072579-BE0260C8-20D2-4F03-B941-A242F46F1F1CQ28081837-FEDBD769-0E5F-4492-8C54-54524C2F85C5Q28084658-30EFFFDD-07CA-4481-909D-BD738841967EQ30545769-0F534E0C-4215-4296-AC96-0521D5DDC55DQ31049878-05E5B2AF-25B7-4163-8916-0D74191D65DAQ31159143-5C2B66A5-44E4-48EA-B03A-7EE3135114DBQ33227649-1E2081A9-2F68-4B06-949C-D8BCB0056B62Q33585597-8BBD39E8-47F6-4705-8436-510700B62FEFQ33766896-D1E9633C-E088-4A45-BBC7-9B83AA1DF6A9Q33940724-30B4B4EA-4377-4BF7-AFD7-AA3413450717Q34048260-AB64CFAD-12BE-4927-B76F-F1B9A3755D1CQ34117950-650D5C75-A609-461B-BBF3-62FAB9BE3629Q34245296-F7E736DA-199A-4C64-98FD-461983C123CFQ34276216-3D9BDA28-DA50-4DB4-8927-94FD1B193378Q34359362-C6554A91-9204-432A-9B75-844DE375273BQ34417212-03243D73-D96C-4893-B1FA-CDA39A9E05EDQ35059670-B49DA261-A61D-4B2D-BBD6-9B139562ABA2Q35071043-934489E0-ADB5-45F2-A3EF-D51B2CFD2142Q35172841-39F43C6B-07AE-481C-A34F-E1C1609A1534Q35178044-165FCA05-49AE-432D-BA10-54D9361511BDQ35197116-F349DE1B-548F-493B-BA14-CA53AE8F0FF1Q35354278-F15A5EEC-1152-4BF1-BA9B-94157E99A182Q35430776-6BF228C5-F8E9-40ED-A284-B99C52BF910FQ35526930-80F01235-A00E-4922-A4ED-7B7356858A35Q35536198-66CEB487-F7C1-4EB7-BDEA-EF67025D5387Q35581450-D24402A9-5966-459C-A7B7-AC4C671B023FQ35583944-11DA859F-B813-42AB-ACA8-C918D7822306Q35770504-87070998-26E0-478B-80A3-7D2EE2A4003CQ35771277-0C3E6372-5091-43C6-890C-293BA997C649Q35772935-08BC887A-C137-4D12-AA76-038DDEFF2F0BQ35811581-F2EF5EC9-E94A-4F52-B538-C5A4DF439607Q35832134-D4A1DBC8-0CA3-451D-AC83-8053F56D4614
P2860
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@ast
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@en
type
label
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@ast
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@en
prefLabel
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@ast
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@en
P2093
P2860
P356
P1433
P1476
Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
@en
P2093
J J V McMurray
N F Murphy
P2860
P304
P356
10.1136/HRT.2002.008748
P407
P577
2004-03-01T00:00:00Z